The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide

Guo Xiao-Hui

首页> 外文期刊>Current medical research and opinion >The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide

【24h】

The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide

机译：短效和长效胰高血糖素样肽1激动剂在2型糖尿病治疗中的价值：艾塞那肽的经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:

机译：背景：

著录项

来源
《Current medical research and opinion》 |2016年第1期|共16页
作者
Guo Xiao-Hui;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Exenatide; GLP-1; Glucagon-like peptide-1; Hyperglycemia; Hypoglycemia; Review; Type 2 diabetes;

机译：艾塞那肽;GLP-1;胰高血糖素样肽-1;高血糖;低血糖;综述;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide [J] . Guo Xiao-Hui Current medical research and opinion . 2016,第1期

机译：短效和长效胰高血糖素样肽1激动剂在2型糖尿病治疗中的价值：艾塞那肽的经验
2. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide [J] . Alatorre Carlos, Lando Laura Fernandez, Yu Maria, Diabetes, obesity & metabolism . 2017,第7期

机译：用胰高血糖素肽-1受体激动剂治疗2型糖尿病患者的治疗模式：与杜拉蛋白质相比，与杜拉替纳肽和左旋蛋白质相比，较高的粘附和持续性
3. Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus [J] . Hulst Abraham H., Polderman Jorinde A. W., Siegelaar Sarah E., British journal of anaesthesia . 2021,第3期

机译：新的长效胰高血糖素样肽-1受体激动剂在糖尿病的术前考虑
4. Digital Health Interventions for Diabetes Self- Management Education/Support in Type 1 2 Diabetes Mellitus [C] . Dumisani Nkhom, Charles Jenya Soko, Pierre Bowrin, Medical Informatics Europe Conference . 2020

机译：糖尿病自我管理教育/ 1型和2型糖尿病患者的数字健康干预措施
5. Glucagon-like peptide-1 delivery for treatment of type 2 diabetes. [D] . Choi, Suna. 2005

机译：胰高血糖素样肽1递送用于治疗2型糖尿病。
6. Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide or with other glucagon-like peptide-1 receptor agonists [O] . Sheila A. Doggrell 2020

机译：在1型糖尿病 - NO Mag1c中的exenatide在exenatide中或与其他胰高血糖素样肽-1受体激动剂
7. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide [O] . Carlos Alatorre, Laura Fernández Landó, Maria Yu, 2017

机译：用胰高血糖素肽-1受体激动剂治疗2型糖尿病患者的治疗模式：与杜拉蛋白质相比，与杜拉替纳肽和Liraglutide相比，与杜拉替金属更高的粘附和持续性

The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide

摘要

著录项

相似文献

相关主题

期刊订阅